Lunai Bioworks (LNAI) Change in Cash (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Change in Cash of $2.7 million for Q1 2026, up 335.78% year-over-year from $611238.0 in Q1 2025, and up 2100.28% quarter-over-quarter from -$133163.0 in Q4 2025.
Lunai Bioworks (LNAI) Change in Cash (2011 - 2026) Analysis & Trends
Lunai Bioworks' Change in Cash history runs 16 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Change in Cash rose 335.78% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.2 million (up 265.76% YoY), while the FY2025 annual figure was -$127767.0, up 92.28% from the prior year.
- Change in Cash for Q1 2026 stood at $2.7 million, up from -$133163.0 in the prior quarter.
- The five-year high for Change in Cash was $2.7 million in Q1 2026, with the low at -$3.9 million in Q4 2022.
- The 5-year median for Change in Cash is -$279494.0 (2023), against an average of -$620743.2.
- Peak annual rise in Change in Cash reached 511542.31% in 2025, while the deepest fall reached 800.25% in 2025.
- Lunai Bioworks' Change in Cash stood at -$3.9 million in 2022, then jumped by 92.75% to -$279494.0 in 2023, then jumped by 132.63% to $91193.0 in 2024, then sank by 246.02% to -$133163.0 in 2025, then soared by 2100.28% to $2.7 million in 2026.
- Business Quant data shows LNAI's Change in Cash at $2.7 million in Q1 2026, -$133163.0 in Q4 2025, and $532108.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | -133,163.00 |
| Sep 30, 2025 | 532,108.00 |
| Jun 30, 2025 | -830,302.00 |
| Mar 31, 2025 | 611,238.00 |
| Dec 31, 2024 | 91,193.00 |
| Sep 30, 2024 | 104.00 |
| Jun 30, 2024 | -92,230.00 |
| Mar 31, 2024 | 68,717.00 |
| Dec 31, 2023 | -279,494.00 |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.17 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -1.98 Mn |
| Mar 31, 2022 | -2.56 Mn |
| Dec 31, 2021 | -1.67 Mn |
| Sep 30, 2021 | -5.29 Mn |
| Jun 30, 2021 | 16.14 Mn |